Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Aug 14, 2024
- Oral Fadraciclib Phase 2 Proof of Concept Study Enrolling Well -
- 065-101 PoC Interim Data Anticipated in the Fourth Quarter of 2024 -
- Management to Host Conference Call at 4:30 pm EDT Today -
0.34
-0.01 (-1.73%)
CYCLACEL PHARMACEUTICALS - CYCC 6 PERP
NASDAQ:CYCCP (2/21/2025, 8:11:33 PM)
7.39
-0.55 (-6.93%)
Find more stocks in the Stock Screener
CYCC Latest News and Analysis
17 days ago - ChartmillThese stocks are moving in today's after hours sessionAfter the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
